A Prospective Phase II Study of Apatinib Plus Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer

被引：0
|
作者：
Ma, K. [1 ]
Xu, Y. [1 ]
Cai, Y. [1 ]
Wang, X. [1 ]
Sun, C. [1 ]
Guo, Y. [1 ]
Qiu, S. [1 ]
机构：
[1] First Hosp Jilin Univ, Changchun, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
small-cell lung cancer; Apatinib; Phase II;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP10.05
引用
收藏
页码：S216 / S217
页数：2
相关论文
共 50 条
  • [1] A Prospective Study of Apatinib in Advanced Small Cell Lung Cancer Patients Failed from Two or More Lines of Chemotherapy
    Liu, Y.
    Hu, X.
    Zhou, S.
    Li, J.
    Liu, P.
    Wang, Y.
    Hao, X.
    Shi, Y.
    Jiang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S573 - S574
  • [2] A phase II study of antiangiogenic therapy (Apatinib) plus chemotherapy as second-line treatment in advanced small cell lung cancer
    Xu, Yinghui
    Wang, Xu
    Sun, Chao
    Gao, Zhiru
    He, Hua
    Qiu, Shi
    Guo, Ye
    Ma, Xiaohui
    Song, Junya
    Ma, Kewei
    CANCER MEDICINE, 2023, 12 (03): : 2979 - 2989
  • [3] A Prospective Study of Apatinib in Advanced Small Cell Lung Cancer Patients Failed from Two or More Lines of Chemotherapy
    Liu, Y.
    Hu, X.
    Jiang, J.
    Zhou, S.
    Liu, P.
    Li, J.
    Wang, Y.
    Hao, X.
    Shi, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2287 - S2287
  • [4] Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial
    Mengru Cao
    Hailing Lu
    Shi Yan
    Hui Pang
    Lichun Sun
    Chunhong Li
    Xuesong Chen
    Wei Liu
    Jing Hu
    Jian Huang
    Ying Xing
    Ningzhi Zhang
    Yingqi Chen
    Ting He
    Danni Zhao
    Yuanyuan Sun
    Lin Zhao
    Xiaomeng Liu
    Li Cai
    BMC Cancer, 23
  • [5] Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial
    Cao, Mengru
    Lu, Hailing
    Yan, Shi
    Pang, Hui
    Sun, Lichun
    Li, Chunhong
    Chen, Xuesong
    Liu, Wei
    Hu, Jing
    Huang, Jian
    Xing, Ying
    Zhang, Ningzhi
    Chen, Yingqi
    He, Ting
    Zhao, Danni
    Sun, Yuanyuan
    Zhao, Lin
    Liu, Xiaomeng
    Cai, Li
    BMC CANCER, 2023, 23 (01)
  • [6] A phase II study of VM-26 plus lonidamine in pretreated small cell lung cancer
    Gridelli, C
    DeMarinis, F
    Rossi, A
    Tucci, E
    Daprile, M
    Cioffi, R
    Cortesi, E
    Migliorino, R
    Pisano, A
    Scognamiglio, F
    DiGiacomo, R
    Bianco, AR
    ANTICANCER RESEARCH, 1997, 17 (2B) : 1277 - 1279
  • [7] A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer
    Smit, EF
    Fokkema, E
    Biesma, B
    Groen, HJM
    Snoek, W
    Postmus, PE
    BRITISH JOURNAL OF CANCER, 1998, 77 (02) : 347 - 351
  • [8] A Prospective Study of Apatinib in Patients with Extensive-Stage Small Cell Lung Cancer After Failure of Two or More Lines of Chemotherapy
    Liu, Yutao
    Hu, Xingsheng
    Jiang, Jun
    Yang, Lin
    Zhou, Shengyu
    Liu, Peng
    Li, Junling
    Wang, Yan
    Hao, Xuezhi
    Shi, Yuankai
    ONCOLOGIST, 2020, 25 (05) : E833 - E842
  • [9] Gemcitabine plus oxaliplatin combination (GEMOX regimen) in pretreated patients with advanced non-small cell lung cancer (NSCLC): A multicenter phase II study
    Kakolyris, Stylianos
    Ziras, Nikolaos
    Vamvakas, Lambros
    Varthalitis, John
    Papakotoulas, Pavlos
    Syrigos, Kostas
    Vardakis, Nikolaos
    Kalykaki, Antonia
    Amarantidis, Kiriakos
    Georgoulias, Vassilis
    LUNG CANCER, 2006, 54 (03) : 347 - 352
  • [10] Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer:: a lung cancer Galician group phase II study
    Casal, Joaquin
    Amenedo, Margarita
    Mel, Jose Ramon
    Anton, Luis Miguel
    Rodriguez-Lopez, Ruben
    Lopez-Lopez, Rafael
    Gonzalez-Ageitos, Ana
    Castellanos, Javier
    Constenla, Manuel
    Tisaire, Jose L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (05) : 725 - 732
12345